Impact of diagnostic labels and management benefit to harms information for low-risk prostate pathology
- DOI
- 10.1093/jnci/djag248
- Published
- 2026-07-24
- Container
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/jnci/djag248,
title = {Impact of diagnostic labels and management benefit to harms information for low-risk prostate pathology},
author = {Katy J L Bell and Farzaneh Boroumand and Zhuohan Wu and Timothy J Wilt and Lisa Parker and Jeremy Millar and Jenna Smith and Kirsten McCaffery and John Brandt Brodersen and Philipp Dahm and Brett Delahunt and Paul Glasziou and Andrew Warden and Lawrence Diller and Christo van Rensburg and Brooke Nickel},
year = {2026},
journal = {JNCI: Journal of the National Cancer Institute},
doi = {10.1093/jnci/djag248},
url = {https://doi.org/10.1093/jnci/djag248}
}RIS
TY - JOUR TI - Impact of diagnostic labels and management benefit to harms information for low-risk prostate pathology AU - Katy J L Bell AU - Farzaneh Boroumand AU - Zhuohan Wu AU - Timothy J Wilt AU - Lisa Parker AU - Jeremy Millar AU - Jenna Smith AU - Kirsten McCaffery AU - John Brandt Brodersen AU - Philipp Dahm AU - Brett Delahunt AU - Paul Glasziou AU - Andrew Warden AU - Lawrence Diller AU - Christo van Rensburg AU - Brooke Nickel PY - 2026 JO - JNCI: Journal of the National Cancer Institute DO - 10.1093/jnci/djag248 UR - https://doi.org/10.1093/jnci/djag248 ER -
APA
Bell, K. J. L., Boroumand, F., Wu, Z., Wilt, T. J., Parker, L., Millar, J., Smith, J., McCaffery, K., Brodersen, J. B., Dahm, P., Delahunt, B., Glasziou, P., Warden, A., Diller, L., Rensburg, C. V., & Nickel, B. (2026). Impact of diagnostic labels and management benefit to harms information for low-risk prostate pathology. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djag248
Source records
- crossref · retrieved 2026-09-27T02:56:53.664Z